Disparities in Genetic Testing for Heritable Solid-Tumor Malignancies

Genetic testing offers providers a potentially life saving tool for identifying and intervening in high-risk individuals. However, disparities in receipt of genetic testing have been consistently demonstrated and undoubtedly have significant implications for the populations not receiving the standar...

Full description

Saved in:
Bibliographic Details
Published inSurgical oncology clinics of North America Vol. 31; no. 1; p. 109
Main Authors Dillon, Jacquelyn, Ademuyiwa, Foluso O, Barrett, Megan, Moss, Haley A, Wignall, Elizabeth, Menendez, Carolyn, Hughes, Kevin S, Plichta, Jennifer K
Format Journal Article
LanguageEnglish
Published United States 01.01.2022
Subjects
Ethnicity
Genetic Testing
Humans
Neoplasms - diagnosis
Neoplasms - genetics
United States
United States
Disparities
Germline genetic testing
Genetic testing
Hereditary cancer
Online AccessGet more information

Cover

More Information
Summary:Genetic testing offers providers a potentially life saving tool for identifying and intervening in high-risk individuals. However, disparities in receipt of genetic testing have been consistently demonstrated and undoubtedly have significant implications for the populations not receiving the standard of care. If correctly used, there is the potential for genetic testing to play a role in decreasing health disparities among individuals of different races and ethnicities. However, if genetic testing continues to revolutionize cancer care while being disproportionately distributed, it also has the potential to widen the existing mortality gap between various racial and ethnic populations.
ISSN:1558-5042
DOI:10.1016/j.soc.2021.08.004